gamma-aminobutyric acid has been researched along with Polyradiculoneuropathy, Chronic Inflammatory Demyelinating in 1 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337)
Excerpt | Relevance | Reference |
---|---|---|
"Healthcare costs for CIDP patients are substantial, with a large burden in pharmacy usage." | 1.40 | Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy. ( Bromberg, MB; Guptill, JT; Krueger, A; Sanders, DB; Sharma, BK; Thompson, AR; Zhu, L, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guptill, JT | 1 |
Bromberg, MB | 1 |
Zhu, L | 1 |
Sharma, BK | 1 |
Thompson, AR | 1 |
Krueger, A | 1 |
Sanders, DB | 1 |
1 other study available for gamma-aminobutyric acid and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Article | Year |
---|---|
Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy.
Topics: Adolescent; Adult; Aged; Algorithms; Amines; Analgesics; Anti-Inflammatory Agents; Comorbidity; Cost | 2014 |